The Yale Spring Heart Failure Symposium is a one-day conference designed to educate physicians and other health care providers about cutting-edge therapies supporting the diagnosis and treatment of heart failure including state-of-the-art treatment, management of comorbid conditions, pulmonary hypertension, cardiomyopathies, mechanical circulatory support, and heart transplantation.

Epilepsy and seizures effect almost 3 million Americans of all ages. Tremendous advances have been made in the treatment of epilepsy over the past decade with drug therapy, surgery, neurostimulation, and ketogenic diets. The wide range of antiepileptic drugs (AEDs) remains the cornerstone of treatment. Even with the plethora of epilepsy therapies now available, the Center for Disease Control and Prevention estimates that at least 45% of people with epilepsy continue to experience seizures becaus...

This course is a unique opportunity for a panel of experts in subspecialty areas within gastroenterology to present the most important new information presented at Digestive Disease Week and within the past year. A valuable experience for those who have attended Digestive Disease Week in addition to those who have not. We are pleased to bring the 16th Annual Yale Digestive Disease Week Review to the regional gastroenterology community.

 DATE TIME April 28, 2023  12:00 PM—4:40 PM EST April 29, 2023 7:00 AM—1:30 PM EST Over the past 20 years, rheumatology has witnessed tremendous therapeutic advances. Progress in treatment with traditional small molecules and the rise of biologic therapy offers improved outcomes for rheumatic disease patients. With advances in efficacy comes increasing therapeutic complexity and the need to avoid harm.In this two-day Yale Symposium, we will bring together ...

Despite therapeutic advances, the prognosis of pulmonary hypertension remains poor which likely reflects in part delayed detection of the disease and scarcity of disease modifying therapies currently available. The former is important especially amongst health care providers given the myriad of conditions that can result in pulmonary hypertension, including chronic liver disease, left heart disease, and connective tissue disease. Early recognition of the pulmonary hypertension and recognizing th...